Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A

Heide Müller-Alouf, Thomas Proft, Thomas M. Zollner, Dieter Gerlach, Eric Champagne, Pierre Desreumaux, Catherine Fitting, Christiane Geoffroy-Fauvet, Joseph E. Alouf, Jean-Marc Cavaillon
Heide Müller-Alouf
Département de Microbiologie des Ecosystèmes, Institut Pasteur de Lille,and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Proft
Department of Molecular Medicine, School of Medicine, University of Auckland, Auckland, New Zealand; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas M. Zollner
Department of Dermatology, University of Frankfurt, Frankfurt/Main, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieter Gerlach
Institute of Experimental Microbiology, Friedrich-Schiller University, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Champagne
INSERM U 395 CHU Purpan, Toulouse, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Desreumaux
Clinique des Maladies de l'Appareil Digestif. Hôpital Claude Huriez, Lille,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Fitting
Department of Physiopathology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christiane Geoffroy-Fauvet
Unité des Toxines Microbiennes,Institut Pasteur, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph E. Alouf
Unité des Toxines Microbiennes,Institut Pasteur, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marc Cavaillon
Department of Physiopathology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.6.4141-4145.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Streptococcal mitogenic exotoxin Z (SMEZ), a superantigen derived from Streptococcus pyogenes, provoked expansion of human lymphocytes expressing the Vβ 2, 4, 7 and 8 motifs of T-cell receptor. SMEZ was pyrogenic in rabbits and stimulated the expression of the T-cell activation markers CD69 and cutaneous lymphocyte-associated antigen. A variety of cytokines was released by human mononuclear leukocytes stimulated with SMEZ, which was 10-fold more active than streptococcal pyrogenic exotoxin A. Th2-derived cytokines were elicited only by superantigens and not by streptococcal cells.

Group A streptococci (Streptococcus pyogenes) provoke a wide spectrum of diseases ranging from skin infections and pharyngitis to more severe diseases such as scarlet fever, deep tissue infections, streptococcal toxic shock syndrome (STSS), and probably chronic diseases such as Kawasaki syndrome and guttate psoriasis (1, 2, 22, 23, 31, 33, 44). Several lines of evidence suggest that these diseases are at least partially mediated by extracellular mitogens that belong to the family of the superantigens (SAgs) (2, 33, 47). These effectors trigger polyclonal expansion of T lymphocytes by simultaneous binding to major histocompatibility complex class II molecules on antigen-presenting cells and T-cell receptor via its Vβ domain (37). The Vβ motifs recognized vary from one SAg to another (7). This process leads to the release of high levels of cytokines by antigen-presenting cells and lymphocytes as widely investigated for streptococcal SAgs (6, 8, 11, 12, 16, 26-28, 34, 35, 41, 42). Cytokine accumulation in vivo results in acute shock and other disorders (16, 19, 20, 41, 47). In this respect, significant levels of SAg (43) and cytokines in the biological fluids were detected in patients with STSS (6, 11, 20, 32, 36, 43).

S. pyogenes SAgs comprise the classical erythrogenic (pyrogenic) exotoxins A and C (SPEA and SPEC), encoded by bacteriophagespeA and speC genes (2, 31); other novel SAgs (2, 17, 25, 33, 34, 38, 46); and the streptococcal mitogenic exotoxin Z (SMEZ) (3, 18, 38), encoded by the gene smez, which displays 24 allelic forms (39). Four newly discovered genes speG, speH, speJ, and smez-2, were identified (reference38 and genomic database at Oklahoma University [www.genome.ou.edu/strep.html ]). Their corresponding recombinant proteins were highly mitogenic for human peripheral blood mononuclear cells (PBMC). We describe here some immunological and biological properties of a potent mitogen released in the culture supernatant of an S. pyogenes strain (strain L) lacking bothspeA and speC genes, isolated from a French patient with STSS. This strain was selected among a number ofspeA- and speC-lacking isolates (40). The mitogen was identified as an SAg corresponding to SMEZ. The pyrogenic and superantigenic properties and the cytokine and skin homing antigen-inducing capacities of SMEZ were investigated in parallel with those of purified SPEA (10) used as a control. The cytokine response of PBMC challenged with heat-killed streptococci was also studied for comparative purposes.

The DNA of strain L was prepared and used for PCR with specific primers for smez, speG, and speH as previously described (38). This procedure revealed that the strain carried smez and speG but not speH. The sequence analysis of smez corresponded to allele 16 of this gene. The mitogenic material of the culture supernatant of strain L was purified by ammonium sulfate precipitation and successive chromatographic procedures as previously described (9). The fraction with the highest mitogenic activity of the final chromatographic step was submitted to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electroblotted onto nitrocellulose (4), and stained with mouse immune serum raised against this fraction. The analysis revealed a single band corresponding to a molecular mass of ca. 25 kDa which was also observed with rabbit anti-SMEZ immune serum.

The T-cell receptor Vβ chain profile analysis was performed by reverse transcription-PCR (7) using RNA from 107 PBMC stimulated for 5 days with the purified mitogen (10 ng/ml), SPEA (10 ng/ml), or phytohemagglutinin A (1 ng/ml) as a control. The mitogen stimulated expansion of T cells expressing Vβ 2, 4, 7, and 8 motifs, which are those reported for the 24.3-kDa recombinant SMEZ (38), while SPEA expanded Vβ 2, 12, 13, 14, and 15 T-cell motifs, in accordance with the literature (45). Therefore, both electrophoretic and Vβ repertoire analyses confirm that the purified mitogen and SMEZ are identical SAgs.

Fever induction in experimental animals challenged with staphylococcal and streptococcal SAgs is one of the most important properties of these effectors (2, 15), which led to the term “pyrogenic exotoxins” for the classical erythrogenic toxins A and C (48). In this respect, a pyrogenicity test was performed in which purified SMEZ (100 ng) was injected into the marginal ear veins of New Zealand White rabbits. Rectal temperature was monitored with a mercury thermometer at hourly intervals for a period of 5 h. Preincubation of the product with polymyxin B (2 μg/ml) was done in parallel as a control to rule out a false-positive pyrogenic response caused by possible lipopolysaccharide contamination (5). The rectal temperature of the rabbits increased by about 1.5°C after 4 h and 1.8°C after 6 h (Table1). Polymyxin B did not affect temperature elevation, confirming that the purified SAg is pyrogenic per se. To our knowledge, the pyrogenicities of other recently described SAgs such as mitogenic factor/SPEF (17, 34, 46), SSA (25), SMEZ (18), and SPEG, SPEH, and SMEZ-2 (38) have not been investigated.

View this table:
  • View inline
  • View popup
Table 1.

Rectal temperatures of three rabbits injected with sterile nonpyrogenic saline, SMEZ, or SMEZ plus polymyxin B

SMEZ preparation was assessed for its ability to stimulate in vitro expression by target cells of the skin-selective lymphocyte homing receptor known as cutaneous lymphocyte-associated antigen (CLA) as already established for other staphylococcal and streptococcal SAgs (21, 49, 50). CLA is known to interact with E-selectin in an interleukin-12 (IL-12)-dependent manner. The experimental assay (49) was performed on 3 × 106 human PBMC for 5 days in the presence of SMEZ preparation (10 and 100 ng/ml), SPEA (100 ng/ml and 1 μg/ml), or RPMI 1640 medium as a control. The antibody HECA-452 (a kind gift from A. M. Duijvestijn, Maastricht, The Netherlands) was used to detect CLA. The antibody Ber-ACT8 (Dako), which recognizes CD103, the β7 chain of the integrin receptor that correlates with α4β7 expression of gut homing T cells, was used as a control. Staining was performed by indirect immunofluorescence with goat anti-mouse immunoglobulin G or goat anti-rat immunoglobulin M F(ab)2-phycoerythrin. In each sample, irrelevant monoclonal antibodies of the appropriate isotype were used as controls. Fluorocytometer analysis was performed on a FACSCalibur (Becton Dickinson, Heidelberg, Germany) using standard procedures with the CellQuest computer program. The results were expressed as percentage of antibody-reactive T cells per total T lymphocytes in a gate set on lymphocyte-sized cells. The T-cell activation marker CD69 detected by specific antibody and the skin-selective homing antigen CLA were significantly expanded in the presence of both SMEZ and SPEA. In contrast, the expression of gut homing receptor CD103 was not affected (Table 2). The SMEZ/SPEA-dependent CLA upregulation may possibly contribute to the pathogenesis of streptococcal SAg-induced skin inflammation as suggested in other studies of SAgs from gram-positive cocci (21).

View this table:
  • View inline
  • View popup
Table 2.

CD69, CLA, and CD103 expression on SPEA- and SMEZ-stimulated T cells

The mitogenic activity of the SAgs tested was evaluated by a lymphocyte proliferation assay on human PBMC as previously described (29). Half-maximal proliferation (10,000 cpm) in response to the purified SMEZ was observed at a concentration of 100 pg/ml, in comparison to 1.8 ng/ml for SPEA (data not shown). Accordingly, SMEZ is 18-fold more potent than SPEA in the lymphocyte proliferation assay.

A further consequence of cell stimulation with SAg is the induction of massive cytokine release by target cells. As shown here, this is also the case with SMEZ, investigated for the first time in this respect. Cytokine release by PBMC challenged with SMEZ (0.1, 1, 10, and 100 ng/ml) was determined as reported earlier for SPEA and SPEC (26-28). PBMC were also stimulated in parallel for comparative purposes with 1 μg of SPEA per ml and 107 CFU of heat-killed (1 h at 70°C), streptococci. The release of 18 cytokines in PBMC cultures after 72 h of incubation was tested (Table 3). Except for IL-6 (27), the cytokines were assayed by enzyme-linked immunosorbent assay with the appropriate antibody kits as previously described (24, 26-28, 30). Transforming growth factor β, RANTES, and MIP-1α were immunoassayed by specific kits (R&D systems, Abington, United Kingdom). Both SMEZ and SPEA elicited the release of substantial amounts of pro- and anti-inflammatory, chemotactic, hematopoietic, and Th1- and Th2-derived cytokines (Table3). However, the cytokine-inducing capacity of SMEZ was ca. 10-fold more potent (on a weight basis) than that of SPEA. Dose- and time-dependent production of certain cytokines in response to various concentrations of SMEZ and 1 μg of SPEA per ml was also investigated. IL-12 was produced in significant amounts starting from 24 h, and optimal release was about 400 pg/ml after 48 h in response to 10 ng of SMEZ. Gamma interferon (IFN-γ) and IL-10 release increased progressively up to 72 h for IFN-γ and 96 h for IL-10 (Fig.1a). Similar results were found for the Th2-derived cytokines IL-4, IL-5, and IL-13 (Fig. 1b). Interestingly, striking differences in cytokine-inducing capacity were found between the SAgs tested and heat-killed streptococcal cells. The latter elicited the production of low amounts of IL-2 and did not trigger detectable tumor necrosis factor beta (TNF-β), IL-4, IL-5, and IL-13 release (Table 3). However, streptococcal cells were highly potent inducers of IFN-γ, TNF-α, IL-12 p40, and IL-12 p70, suggesting that the bacteria themselves may evoke cytokine release via their cell wall components, particularly peptidoglycan (13), and thereby could contribute with SAgs to the development of cytokine-mediated streptococcal pathological disorders.

View this table:
  • View inline
  • View popup
Table 3.

In vitro cytokine-inducing capacities of SMEZ, SPEA, and heat-killed group A streptococci in human PBMC

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

(a) Time- and dose-dependent in vitro release of IL-12, IFN-γ and IL-10 by human PBMC in response to SMEZ and SPEA.Embedded Image, control (RPMI); Embedded Image, SMEZ (0.1 ng/ml); □, SMEZ (1 ng/ml);Embedded Image, SMEZ (10 ng/ml); ■, SMEZ (100 ng/ml); ●, SPEA, (1 μg/ml). Data represent means ± standard errors for cells from five donors except for IL-12, data for which are representative of one experiment out of three. (b) Time and dose-dependent in vitro release of IL-4, IL-5, and IL-13 by human PBMC. Symbols are the same as for panel a. Data represent means ± standard errors for the cells from five donors.

A significant feature of the SAgs investigated here is their capacity to induce the release of Th2-derived cytokines as already documented (27, 28, 41). The production of these cytokines raises the question of the possible involvement of bacterial SAgs in the pathogenesis of diseases other than acute streptococcal and staphylococcal diseases, particularly in certain allergic and nonallergic diseases (14, 19, 20). The present results suggest that SMEZ is a potential pathogenicity factor of S. pyogenes that might play an important role in streptococcal diseases.

ACKNOWLEDGMENTS

This work was supported by the Institut Pasteur de Lille, the Centre Hospitalier Regional et Universitaire de Lille (grant 96/38/9713), and Association F. Aupetit.

Notes

Editor: J. T. Barbieri

FOOTNOTES

    • Received 27 November 2000.
    • Returned for modification 15 January 2001.
    • Accepted 5 March 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Abe J. B.,
    2. Kotzin L.,
    3. Jugo K.,
    4. Melish M. E.,
    5. Glode M. P,
    6. Kohsaka T.,
    7. Leung D. Y. M.
    Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease.Proc. Natl. Acad. Sci. USA89199240664070
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Alouf J. E.,
    2. Müller-Alouf H.,
    3. Köhler W.
    Superantigenic Streptococcus pyogenes erythrogenic/pyrogenic exotoxins The comprehensive sourcebook of bacterial protein toxins. Alouf J. E., Freer J. H. 1999 567 588 Academic Press London, England
  3. 3.↵
    1. Arcus V. L.,
    2. Proft T.,
    3. Sigzell J. A.,
    4. Baker H. M.,
    5. Fraser J. D.,
    6. Baker E. N.
    Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two superantigens from Streptococcus pyogenes.J. Mol. Biol.299200011591168
    OpenUrl
  4. 4.↵
    1. Burnette W. H.
    Western blotting: electrophoretic transfer of proteins from SDS polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.Anal. Biochem.1121981195203
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Cavaillon J.-M.,
    2. Haeffner-Cavaillon N.
    Polymyxin B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin.Mol. Immunol.231986965969
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Cavaillon J. M.,
    2. Müller-Alouf H.,
    3. Alouf J. E.
    Cytokines in streptococcal infections.Adv. Exp. Med. Biol.4181997929931
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Champagne E.,
    2. Huchenq A.,
    3. Sevin J.,
    4. Casteran N.,
    5. Rubin B.
    An alternative method for T-cell receptor repertoire analysis: clustering of human V-beta subfamilies selected in response to staphylococcal enterotoxins B and E.Mol. Immunol.301993877886
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Fast D. J.,
    2. Schlievert P. M.,
    3. Nelson R. D.
    Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.Infect. Immun.571989291294
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Geoffroy-Fauvet C.,
    2. Müller-Alouf H.,
    3. Champagne E.,
    4. Cavaillon J. M.,
    5. Alouf J. E.
    Identification of a new extracellular superantigenic mitogen from group A Streptococci.Zentbl. Bakteriol. Suppl.2419949192
    OpenUrl
  10. 10.↵
    1. Gerlach D.,
    2. Köhler W.,
    3. Knöll H.,
    4. Moràvek L.,
    5. Weeks R. C.,
    6. Ferretti J. J.
    Purification and characterisation of Streptococcus pyogenes erythrogenic toxin type A produced by a cloned gene in Streptococcus sanguis.Zentbl. Bakteriol.2661987347358
    OpenUrl
  11. 11.↵
    1. Hackett S. P.,
    2. Stevens D. L.
    Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.J. Infect. Dis.1651992879885
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Hackett S. P.,
    2. Stevens D. L.
    Superantigen associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β.J. Infect. Dis.1681993232235
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Henderson B.,
    2. Poole S.,
    3. Wilson M.
    Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.Microbiol. Rev.601996316341
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Hofer M. F.,
    2. Lester M. R.,
    3. Schlievert P. M.,
    4. Leung D. Y. M.
    Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.Clin. Exp. Allergy25199512181227
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Hribalova V.,
    2. Knöll H.,
    3. Gerlach D.,
    4. Köhler W.
    Purification and characterization of erythrogenic toxins. II. In vivo biological activities of erythrogenic toxin produced by Streptococcus pyogenes strain NY-5.Zentbl. Bakteriol.2481980314322
    OpenUrl
  16. 16.↵
    1. Imanishi K.,
    2. Inada K.,
    3. Akatsuda H.,
    4. Gu Y.,
    5. Igarishi H.,
    6. Uchiyama T.
    Tumor necrosis factor production by human T cells stimulated with bacterial superantigens.Int. J. Immunopharmacol.171995841848
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Iwasaki M.,
    2. Igarashi H.,
    3. Hinuma Y.,
    4. Yutsudo T.
    Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor.FEBS Lett.3311993187192
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Kamezawa Y.,
    2. Nakahara T.,
    3. Nakano S.,
    4. Abe Y.,
    5. Nozaki-Renard J.,
    6. Isono T.
    Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.Infect. Immun.65199738283833
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. König B.,
    2. Neuber K.,
    3. König W.
    Responsiveness of peripheral blood mononulear cells from normal and atopic donors to microbial superantigens.Int. Arch. Allergy Immunol.1061995124133
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Kotb M.
    Superantigens in human diseases.Clin. Microbiol. Newsl.191997145150
    OpenUrl
  21. 21.↵
    1. Leung D. Y. M.,
    2. Gately M.,
    3. Trumble A.,
    4. Ferguson-Darnell B.,
    5. Schlievert P. M.,
    6. Pickler L.
    Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutanous lymphocyte-associated antigen via stimulation of IL-12.J. Exp. Med.1811995747753
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Leung D. Y. M.,
    2. Travers J. B.,
    3. Giorno R.,
    4. Norris D. A.,
    5. Skinner R.,
    6. Aelion J.,
    7. Kazemi L. V.,
    8. Kim M. H.,
    9. Trumble A. E.,
    10. Kotb M.,
    11. Schlievert P. M.
    Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.J. Clin. Investig.96199521061212
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Leung D. Y. M.
    Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.Clin. Exp. Immunol.104 (Suppl. 1)19964954
    OpenUrl
  24. 24.↵
    1. Marty C.,
    2. Misset B.,
    3. Tamion F.,
    4. Fitting C.,
    5. Carlet J.,
    6. Cavaillon J.-M.
    Circulating interleukin-8 concentrations in patients with muliple organ failure of septic and non septic origin.Crit. Care Med.221994673679
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Mollick J. A.,
    2. Miller G. G.,
    3. Musser J. M.,
    4. Cook R. G.,
    5. Grossman D.,
    6. Rich R. R.
    A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.J. Clin. Investig.921993710719
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Müller-Alouf H.,
    2. Alouf J. E.,
    3. Gerlach D.,
    4. Ozegowski J. H.,
    5. Fitting C.,
    6. Cavaillon J.-M.
    Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.Infect. Immun.62199449154921
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Müller-Alouf H.,
    2. Alouf J. E.,
    3. Gerlach D.,
    4. Ozegowski J. H.,
    5. Fitting C.,
    6. Cavaillon J. M.
    Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens.Infect. Immun.64199614501453
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Müller-Alouf H.,
    2. Gerlach D.,
    3. Desreumaux P.,
    4. Leportier C.,
    5. Alouf J. E.,
    6. Capron M.
    Streptococcal pyrogenic exotoxin A (SPEA) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells.Microb. Pathog.231997265272
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Müller-Alouf H.,
    2. Geoffroy C.,
    3. Geslin P.,
    4. Bouvet A.,
    5. Felten A.,
    6. Günther E.,
    7. Ozegowski J.-H.,
    8. Alouf J. E.
    Streptococcal pyrogenic exotoxin A, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.Zentbl. Bakteriol.2861997421433
    OpenUrl
  30. 30.↵
    1. Muñoz C.,
    2. Carlet J.,
    3. Fitting C.,
    4. Misset B.,
    5. Pleriot J.-P.,
    6. Cavaillon J.-M.
    Dysregulation of in vitro cytokine production by monocytes during sepsis.J. Clin. Investig.88199117471754
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Musser J. M.,
    2. Hauser A. R.,
    3. Kim M. H.,
    4. Schlievert P. M.,
    5. Nelson K.,
    6. Selander R. K.
    Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.Proc. Natl. Acad. Sci. USA88199126682672
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Nadal D.,
    2. Lauener R. P.,
    3. Bregger C. P.,
    4. Kaufhold A.,
    5. Simma B.,
    6. Lütticken R.,
    7. Seger A.
    T cell activation and cytokine release in streptococcal toxic shock syndrome.J. Pediatr.1221993727729
    OpenUrlPubMedWeb of Science
  33. 33.↵
    1. Norgren M.,
    2. Eriksson A.
    Streptococcal superantigens and their role in the pathogenesis of severe infections.J. Toxicol. Toxin Rev.161997132
    OpenUrlCrossRef
  34. 34.↵
    1. Norrby-Teglund A.,
    2. Newton D.,
    3. Kotb M.,
    4. Holm S. E.,
    5. Norgren M.
    Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).Infect. Immun.62199452275233
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Norrby-Teglund A.,
    2. Lustig R.,
    3. Kotb M.
    Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates.Infect. Immun.65199752095215
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Norrby-Teglund A.,
    2. Pauksens K.,
    3. Norgren M.,
    4. Holm S. E.
    Correlation between serum TNF alpha and IL-6 levels and severity of group A streptococcal infections.Scand. J. Infect. Dis.271995125
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Papageorgiou A. C.,
    2. Collins C. M.,
    3. Gutman D. M.,
    4. Kline J. B.,
    5. O'Brien S. M.,
    6. Tranter H. S.,
    7. Acharya K. R.
    Structural basis for recognition of superantigen streptococcal pyrogenic exotoxin A (SPEA1) by MHC class II molecules and T cell receptors.EMBO J.181999921
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Proft T.,
    2. Moffatt S. L.,
    3. Berkhahn C. J.,
    4. Fraser J. D.
    Identification and characterization of novel superantigens from Streptococcus pyogenes.J. Exp. Med.189199989102
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Proft T.,
    2. Moffat S. L.,
    3. Weller K. D.,
    4. Paterson A.,
    5. Martin D.,
    6. Fraser D.
    The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure and significant antigenic variation.J. Exp. Med.191200017651776
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Reichardt W.,
    2. Müller-Alouf H.,
    3. Alouf J. E.,
    4. Köhler W.
    Erythrogenic toxins A, B and C: occurrence of genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.FEMS Microbiol. Lett.1001992313322
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Rink L.,
    2. Luhm J.,
    3. Koester M.,
    4. Kirchner H.
    Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation.J. Interferon Cytokine Res.1619964147
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Sriskandan S.,
    2. Evans T. J.,
    3. Cohen J.
    Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFNγ.J. Immunol.156199624302435
    OpenUrlAbstract
  43. 43.↵
    1. Sriskandan S.,
    2. Moyes D.,
    3. Cohen J.
    Detection of bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic shock syndrome.Lancet348199613151316
    OpenUrlPubMedWeb of Science
  44. 44.↵
    1. Stevens D. L.,
    2. Tanner M. H.,
    3. Winship J.,
    4. Swarts R.,
    5. Ries K. M.,
    6. Schlievert P. M.,
    7. Kaplan E.
    Severe group A streptococci associated with toxic shock like syndrome and scarlet fever toxin A.N. Engl. J. Med.321198917
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Tomai M. A.,
    2. Schlievert P. M.,
    3. Kotb M.
    Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.Infect. Immun.601992701705
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Toyosaki T.,
    2. Yoshioka T.,
    3. Tsuruta Y.,
    4. Yutsudo T.,
    5. Iwasaki M.,
    6. Suzuki R.
    Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B and C.Eur. J. Immunol.26199626932701
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Uchiyama T.,
    2. Yan X.-J.,
    3. Imanishi K.,
    4. Yagi J.
    Bacterial superantigens—mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases.Microbiol. Immunol.381994245256
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Watson D. W.
    Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.J. Exp. Med.1111960255284
    OpenUrlAbstract
  49. 49.↵
    1. Zollner T. M.,
    2. Munk M. E.,
    3. Keller T.,
    4. Nuber V.,
    5. Boenhnke W. H.,
    6. Kaufmann S. H. E.,
    7. Duijvestijn A. M.,
    8. Sterry W.,
    9. Kaufmann R.
    The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes.Immunol. Lett.491996111116
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    1. Zollner T. M.,
    2. Nuber V.,
    3. Duijvestijn A. M.,
    4. Boehnke W. H.,
    5. Kaufmann R.
    Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytes.Exp. Dermatol.61997161166
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A
Heide Müller-Alouf, Thomas Proft, Thomas M. Zollner, Dieter Gerlach, Eric Champagne, Pierre Desreumaux, Catherine Fitting, Christiane Geoffroy-Fauvet, Joseph E. Alouf, Jean-Marc Cavaillon
Infection and Immunity Jun 2001, 69 (6) 4141-4145; DOI: 10.1128/IAI.69.6.4141-4145.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A
Heide Müller-Alouf, Thomas Proft, Thomas M. Zollner, Dieter Gerlach, Eric Champagne, Pierre Desreumaux, Catherine Fitting, Christiane Geoffroy-Fauvet, Joseph E. Alouf, Jean-Marc Cavaillon
Infection and Immunity Jun 2001, 69 (6) 4141-4145; DOI: 10.1128/IAI.69.6.4141-4145.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
bacterial toxins
cytokines
Exotoxins
membrane proteins
Pyrogens
Streptococcus pyogenes
superantigens

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522